Market Research Report
Cardiovascular Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024
|Published by||IMARC Services Private Limited||Product code||788422|
|Published||Content info||135 Pages
Delivery time: 2-3 business days
|Cardiovascular Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024|
|Published: February 11, 2019||Content info: 135 Pages||
The global cardiovascular implants market was worth US$ 19.8 Billion in 2018. Cardiovascular implants are used for patients suffering from cardiovascular conditions such as heart failure, myocardial infarction, and peripheral arterial and coronary artery diseases. Depending on their intended use, there are two broad categories of cardiovascular implants. The first type of implants remain inside the patients' body throughout their lives to support or perform heart functions. On the other hand, temporary implants are utilized during surgeries or other medical procedures for taking over or managing heart functions. The growing prevalence of heart diseases, owing to changing dietary patterns, sedentary lifestyles and rising geriatric population, has resulted in high demand for cardiovascular implants across the globe.
Rising prevalence of cardiovascular disorders represents a key factor driving the demand of cardiovascular implants. Catalyzed by unhealthy diets and sedentary lifestyles, the prevalence of various cardiovascular disorders has increased across both developed and developing countries. Improving efficacy and safety of cardiovascular implants represents another major factor spurring the market growth. For instance, recent advancements in technology have opened opportunities for developing smart stent devices which can improve the diagnosis as well treatment of previously unmanageable conditions such as atherosclerosis and central line access failure. Apart from this, various government and non-profit organizations are also taking initiatives to improve the affordability of these devices. Other factors driving this market include ageing population, development in medical infrastructure, growing awareness levels and rising popularity of minimally invasive surgeries. Looking forward, the market value is projected to exceed US$ 27.1 Billion by 2024, expanding at a CAGR of around 5% during 2019-2024.
Based on the product type, the market has been segmented into coronary stent, ICD, heart valve, implanted cardiac pacemaker, CRT device and peripheral stent.
Based on the material, the market has been segmented into metals and alloys, polymers and biological materials.
Based on the procedure type, the market has been segmented into angioplasty and open-heart surgery.
Based on the indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, congestive heart failure and others.
Region-wise, the market has been segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The competitive landscape of the market has also been examined with some of the key players being Biotronik, Abbott Laboratories, AMG International, B-Braun, Johnson & Johnson, W.L. Gore & Associates, Medtronic, Boston Scientific, Sorin, Edwards Lifesciences, Fortimedix, Neovasc Inc., On-X Life Technologies, Proxy Biomedical, Reva Medical and Shree Pacetronix Ltd.